Analyst Price Targets — KMDA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 11, 2026 3:01 pm | Annabel Samimy | Stifel Nicolaus | $11.00 | $8.55 | StreetInsider | Stifel Reiterates Buy Rating on Kamada Ltd. (KMDA) |
| December 9, 2025 11:11 am | — | H.C. Wainwright | $13.00 | $6.73 | TheFly | Kamada price target raised to $13 from $11 at H.C. Wainwright |
| November 13, 2024 4:05 pm | Annabel Samimy | Stifel Nicolaus | $20.00 | $6.03 | StreetInsider | Kamada Ltd. (KMDA) PT Raised to $20 at Stifel |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for KMDA

Findings from analyses of CMV high-risk lung transplant recipients suggest CYTOGAM use is associated with improved clinical outcomes, supporting increased CYTOGAM utilization Findings from analyses of CMV high-risk lung transplant recipients suggest CYTOGAM use is associated with improved clinical outcomes, supporting increased CYTOGAM utilization

REHOVOT, Israel and HOBOKEN, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived therapies field, today announced FDA approval of the Company's new in-house Rapid Fluorescent Focus Inhibition Test (RFFIT) laboratory. RFFIT is…

Kamada NASDAQ: KMDA reiterated its full-year 2026 outlook after reporting first-quarter results that management said were in line with expectations, excluding a temporary shipment delay that shifted revenue into April.

Kamada Ltd. (KMDA) Q1 2026 Earnings Call Transcript

Although the revenue and EPS for Kamada (KMDA) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for KMDA.
U.S. House Trading
No House trades found for KMDA.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
